Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.38 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17025752 | 0.93 | ABCB1 (0.47) | ABCB1KCNK3KCNK9 | |
| SCHEMBL17025766 | 0.92 | ABCB1 (0.54) | ABCB1NPC1RAB9A | |
| SCHEMBL22363210 | 0.92 | ABCB1 (0.54) | ABCB1NPC1RAB9A | |
| SCHEMBL19946425 | 0.92 | ABCB1 (0.54) | ABCB1NPC1RAB9A | |
| SCHEMBL17025797 | 0.90 | ABCB1 (0.52) | ABCB1 | |
| SCHEMBL17025792 | 0.90 | ABCB1 (0.47) | ABCB1NPC1RAB9A | |
| SCHEMBL27237889 | 0.85 | ABCB1 (0.45) | ABCB1KCNK3KCNK9 | |
| SCHEMBL17025770 | 0.84 | ABCB1 (0.40) | ABCB1NPC1RAB9AKCNK3KCNK9 | |
| SCHEMBL6123269 | 0.84 | ABCB1 (0.50) | ABCB1NPC1RAB9A | |
| SCHEMBL19946450 | 0.84 | ABCB1 (0.46) | ABCB1NPC1RAB9AKCNK3KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150240244-A1 | BIOAVAILABLE DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES VIA AN ECDYSONE RECEPTOR COMPLEX | BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT (GB) | 2015-08-27 | — | — | US | claimed |
| EP-2460786-A1 | Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | Intrexon Corporation (US) | 2012-06-06 | — | — | EP | claimed |
| EP-4382913-A2 | MODULATING EXPRESSION OF POLYPEPTIDES VIA NEW GENE SWITCH EXPRESSION SYSTEMS | Precigen, Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-2463269-B1 | Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORP (US) | 2016-09-28 | — | — | EP | disclosed |
| EP-2460786-B1 | Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex | INTREXON CORP (US) | 2016-01-13 | — | — | EP | disclosed |